These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
722 related items for PubMed ID: 18779929
1. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels. D'Onofrio M, Faccioli N, Zamboni G, Malagò R, Caffarri S, Fattovich G, Mucelli RP. Radiol Med; 2008 Oct; 113(7):978-91. PubMed ID: 18779929 [Abstract] [Full Text] [Related]
4. [Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study]. Tranquart F, Correas JM, Ladam Marcus V, Manzoni P, Vilgrain V, Aube C, Elmaleh A, Chami L, Claudon M, Cuilleron M, Diris B, Garibaldi F, Lucidarme O, Marion D, Beziat C, Rode A, Tasu JP, Trillaud H, Bleuzen A, Le Gouge A, Giraudeau B, Rusch E. J Radiol; 2009 Jan; 90(1 Pt 2):109-22. PubMed ID: 19212279 [Abstract] [Full Text] [Related]
6. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J. Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697 [Abstract] [Full Text] [Related]
8. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Strobel D, Seitz K, Blank W, Schuler A, Dietrich CF, von Herbay A, Friedrich-Rust M, Bernatik T. Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669 [Abstract] [Full Text] [Related]
9. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue]. Hohmann J, Skrok J, Puls R, Albrecht T. Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698 [Abstract] [Full Text] [Related]
10. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L, Pozzi-Mucelli R. Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314 [Abstract] [Full Text] [Related]
13. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers. Quaia E, Stacul F, Gaiani S, Ricci P, Passariello R, Curzio D, Pozzi Mucelli R. Radiol Med; 2004 Aug; 108(1-2):71-81. PubMed ID: 15269691 [Abstract] [Full Text] [Related]
17. Diagnostic efficacy of contrast-enhanced ultrasound, dynamic contrast-enhanced MRI combined with tumor markers AFP and DCP for primary hepatocellular carcinoma. Guo X, Tian C, Liu G, Mi X, Gao D. Biotechnol Genet Eng Rev; 2024 Apr; 40(1):623-637. PubMed ID: 36877612 [Abstract] [Full Text] [Related]
18. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? Leoni S, Piscaglia F, Granito A, Borghi A, Galassi M, Marinelli S, Terzi E, Bolondi L. Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066 [Abstract] [Full Text] [Related]